Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature
Linezolid-induced PRES is rare but clinically significant. Our case highlights potential hemorrhagic complications and delayed recovery, underscoring the need for early recognition and prompt management.
Authors
- P U Shah
- Olga R. Thon (ORCID: https://orcid.org/0009-0009-4600-4123)
- Jamir Pitton Rissardo (ORCID: https://orcid.org/0000-0001-6179-2177)
- Joshua Santucci (ORCID: https://orcid.org/0000-0002-6324-4171)
- K. Piotrowski
- Aswathi Sajeendran
- Ana Leticia Fornari Caprara
Institutions
- Cooper University Hospital (US)
- Cooper Medical School of Rowan University (US)
- Federal Reserve Bank of Chicago (US)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1097/wnf.0000000000000674
- Primary Topic
- Neurological Complications and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00